EP3280795

COMBINATION OF CHIMERIC ANTIGEN RECEPTOR THERAPY AND AMINO PYRIMIDINE DERIVATIVES

  • Status:
    EP einkaleyfi: Þýðing ekki lögð inn
  • EP appl. date:
    7.4.2016
  • EP published:
    24.3.2021
  • EP application number:
    16718786.3
  • Max expiry date:
    6.4.2036
  • Title:
    COMBINATION OF CHIMERIC ANTIGEN RECEPTOR THERAPY AND AMINO PYRIMIDINE DERIVATIVES

Timeline

Today
7.4.2016EP application
24.3.2021EP Publication

Owner

  • Name:
    Novartis AG
  • Address:
    Lichtstrasse 35, 4056 Basel, CH
  • Name:
    The Trustees of The University of Pennsylvania
  • Address:
    3160 Chestnut Street Suite 200, Philadelphia, PA 19104, US

Inventor

  • Name:
    BYRD, John
  • Address:
    Columbus, OH 43212, US
  • Name:
    DUBOVSKY, Jason
  • Address:
    Columbus, OH 43235, US
  • Name:
    JOHNSON, Amy
  • Address:
    Dublin, OH 43016, US
  • Name:
    JUNE, Carl, H.
  • Address:
    Merion Station, PA 19066, US
  • Name:
    MUTHUSAMY, Natarajan
  • Address:
    Galloway, OH, US
  • Name:
    PORTER, David, L.
  • Address:
    Springfield, PA 19064, US
  • Name:
    WASIK, Mariusz
  • Address:
    Ardmore, PA 19003, US
  • Name:
    ANGST, Daniela
  • Address:
    4002 Basel, CH
  • Name:
    FRAIETTA, Joseph, A.
  • Address:
    Williamstown, NJ 08094, US
  • Name:
    GESSIER, Francois
  • Address:
    4002 Basel, CH
  • Name:
    GILL, Saar
  • Address:
    Philadelphia, PA 19106, US
  • Name:
    MAUS, Marcela
  • Address:
    Lexington, MA 02421, US
  • Name:
    RUELLA, Marco
  • Address:
    Philadelphia, PA 19143, US
  • Name:
    VULPETTI, Anna
  • Address:
    4002 Basel, CH

Priority

  • Number:
    201562144188 P
  • Date:
    7.4.2015
  • Country:
    US

Classification

  • Categories:
    A61K 31/505, A61K 31/506, A61K 45/06, A61P 35/00, A61P 35/02

Upload documents